Investigation of Motivational Interviewing and Prevention Consults to Achieve Cardiovascular Targets
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Coronary Artery Disease
- Sponsor
- NYU Langone Health
- Enrollment
- 400
- Locations
- 1
- Primary Endpoint
- Reduction of Non-HDL cholesterol
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
The objective of IMPACT (Investigation of Motivational Interviewing and Prevention Consults to Achieve Cardiovascular Targets) is to determine the best management strategy for patients undergoing cardiovascular intervention. IMPACT is a prospective randomized trial that will enroll 400 patients post-cardiovascular intervention. The study will compare different cardiovascular prevention strategies: (1) usual care, (2) cardiovascular prevention consult, and (3) cardiovascular prevention consult with a behavioral intervention program over a 6-month period. The trial hypothesis is that for patients undergoing a cardiovascular intervention, a prevention consult and behavioral intervention is superior to usual care in reducing cardiovascular risk. The primary endpoint will be non-HDL cholesterol. Secondary endpoints include other lipid values, metabolic risk, smoking cessation, physical activity, nutritional status, medication adherence and quality of life. IMPACT is scheduled to begin enrollment in the June of 2012.
Detailed Description
SPECIFIC AIMS Primary aim: The primary aim is that a targeted Cardiovascular Prevention consult will reduce non-HDL cholesterol compared to usual care at 6 months post-intervention. Secondary aim: The secondary aim is that a targeted Cardiovascular Prevention consult plus a behavioral intervention will reduce non-HDL cholesterol compared to usual care at 6 months post-intervention.
Investigators
Eligibility Criteria
Inclusion Criteria
- •at least 21 years of age or older
- •Subjects scheduled to undergo a percutaneous coronary or peripheral vascular intervention
- •Patients must have the ability to understand and the willingness to sign a written informed consent document
Exclusion Criteria
- •Life expectancy less than 1-year
- •Inability to walk
Outcomes
Primary Outcomes
Reduction of Non-HDL cholesterol
Time Frame: 6 months
Secondary Outcomes
- Nutrition(6 months)
- Metabolic risk factors(6 months)
- Physical Activity(6 months)
- Quality of life(6 months)
- Smoking cessation(6 months)
- Optimal medical regimen(6 months)
- Cardiovascular risk(6 months)
- Cardiovascular events(5 years)
- Lipids(6 months)
- Medication Adherence(6 months)